Squalene-Based Influenza Vaccine Adjuvants and Their Impact on the Hemagglutinin-Specific B Cell Response
Influenza infections continue to cause significant annual morbidity and mortality despite ongoing influenza vaccine research. Adjuvants are administered in conjunction with influenza vaccines to enhance the immune response and strengthen protection against disease. Squalene-based emulsion adjuvants...
Main Authors: | Phuong Nguyen-Contant, Mark Y. Sangster, David J. Topham |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/10/3/355 |
Similar Items
-
Role of Memory B Cells in Hemagglutinin-Specific Antibody Production Following Human Influenza A Virus Infection
by: Mark Y. Sangster, et al.
Published: (2019-09-01) -
Next-Generation Influenza HA Immunogens and Adjuvants in Pursuit of a Broadly Protective Vaccine
by: Kaito A. Nagashima, et al.
Published: (2021-03-01) -
Squalene Emulsions for Parenteral Vaccine and Drug Delivery
by: Christopher B. Fox
Published: (2009-09-01) -
Influenza Hemagglutinin Nanoparticle Vaccine Elicits Broadly Neutralizing Antibodies against Structurally Distinct Domains of H3N2 HA
by: Alyse D. Portnoff, et al.
Published: (2020-02-01) -
Neutralizing Antibodies Targeting the Conserved Stem Region of Influenza Hemagglutinin
by: Sabari Nath Neerukonda, et al.
Published: (2020-07-01)